# Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

> **NCT01817075** · PHASE3 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 177 (actual)

## Conditions studied

- Bacterial Infection
- Benign Neoplasm
- Malignant Neoplasm
- Methicillin-Resistant Staphylococcus Aureus Infection
- Myeloid Neoplasm
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood Acute Myeloid Leukemia

## Interventions

- **PROCEDURE:** Chlorhexidine Gluconate Skin Cleanser
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Mild Soap Skin Cleanser
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT01817075
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-04
- **Primary completion:** 2019-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2021-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01817075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01817075, "Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01817075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*